Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,474,089 shares of CSTL stock, worth $49.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,474,089

Previous 1,378,005 6.97%

Holding current value

$49.3 Million

Previous $28.1 Million 19.29%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$14.65 - $24.65 $1.41 Million - $2.37 Million	96,084 Added 6.97%	1,474,089 $33.6 Million
Q2 2025 Aug 12, 2025	BUY	$15.8 - $21.98 $2.81 Million - $3.91 Million	177,783 Added 14.81%	1,378,005 $28.1 Million
Q1 2025 May 13, 2025	BUY	$18.76 - $32.72 $3.77 Million - $6.57 Million	200,756 Added 20.09%	1,200,222 $24 Million
Q4 2024 Feb 13, 2025	BUY	$26.52 - $34.67 $3.57 Million - $4.67 Million	134,645 Added 15.57%	999,466 $26.6 Million
Q3 2024 Nov 07, 2024	BUY	$17.4 - $31.47 $955,033 - $1.73 Million	54,887 Added 6.78%	864,821 $24.7 Million
Q2 2024 Aug 09, 2024	BUY	$18.84 - $24.94 $1.14 Million - $1.51 Million	60,675 Added 8.1%	809,934 $17.6 Million
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $1.54 Million - $2.16 Million	85,377 Added 12.86%	749,259 $16.6 Million
Q4 2023 Feb 07, 2024	BUY	$12.19 - $22.43 $1.32 Million - $2.43 Million	108,481 Added 19.53%	663,882 $14.3 Million
Q3 2023 Nov 09, 2023	BUY	$13.28 - $20.3 $874,063 - $1.34 Million	65,818 Added 13.44%	555,401 $9.38 Million
Q2 2023 Aug 09, 2023	BUY	$11.66 - $26.0 $69,155 - $154,206	5,931 Added 1.23%	489,583 $6.72 Million
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $3.11 Million - $4.56 Million	159,966 Added 49.42%	483,652 $11 Million
Q4 2022 Feb 09, 2023	BUY	$18.08 - $30.0 $1.54 Million - $2.56 Million	85,198 Added 35.72%	323,686 $7.62 Million
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $1.04 Million - $1.59 Million	46,410 Added 24.16%	238,488 $6.22 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $1.12 Million - $3.21 Million	69,700 Added 56.95%	192,078 $4.22 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $274,581 - $388,900	8,278 Added 7.26%	122,378 $5.49 Million
Q4 2021 Feb 09, 2022	BUY	$39.06 - $67.58 $2.34 Million - $4.04 Million	59,783 Added 110.06%	114,100 $4.89 Million
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $3.27 Million - $4.21 Million	54,317 New	54,317 $3.61 Million
Q2 2021 Aug 12, 2021	SELL	$50.07 - $76.78 $7.16 Million - $11 Million	-142,988 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $7.21 Million - $11.9 Million	122,306 Added 591.36%	142,988 $9.76 Million
Q4 2020 Feb 25, 2021	BUY	$43.6 - $73.05 $901,735 - $1.51 Million	20,682 New	20,682 $1.39 Million

Others Institutions Holding CSTL

# of Institutions

188

Shares Held

27.1M

Call Options Held

42.2K

Put Options Held

9.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $880M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History